Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03911011
Other study ID # 2018/2478
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 7, 2019
Est. completion date June 20, 2021

Study information

Verified date February 2019
Source Haukeland University Hospital
Contact Oyvind Thomassen, PhD
Phone +4797718721
Email oyvt@helse-bergen.no
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The literature describes and report neurologic intact patients surviving an avalanche several hours after they were buried. The most important factor for surviving more than 15-35 min of burial is considered to be the presence of an air-filled space around the head and neck, termed an air pocket. Little is known how the inspired air is influenced by the patients breathing and how oxygen and carbon dioxide diffuse through snow.


Description:

In a controlled and simulated avalanche scenario the investigators want to investigate how oxygen (O2) and carbon dioxide (CO2) diffuse and how rebreathing of CO2 in addition to mild hypoxia influence standardized physiological parameters in two scenarios: Fresh air and no fresh air delivered into the air pocket. The project is a field study designed to measure and document gas diffusion through snow. The outcome measures are: (1) Concentration of O2 and CO2 in the air pocket and 50 cm from the pocket. (2) Time interval for development of threshold values for concentration of O2 and CO2. The investigators will also monitor physiologic measures such as: Electrocardiogram (ECG), continuous invasive blood pressure, cerebral oximetry, continuous pulse oximetry, transthoracic impedance, and gas content in expired air. Subjective evaluation of comfort will also be scored. Twenty healthy young volunteers with written consent to participate will be used as test subjects.

The study may have a clinical consequence for better outcome, for victims of avalanches by providing additional air or oxygen close to the patient. We will also measure specific body measures and spirometry.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date June 20, 2021
Est. primary completion date June 8, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Healthy, non smoking, normal BMI

Exclusion Criteria:

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Fresh air
Fresh air insufflation of 2 L/min toward mouth/nose.

Locations

Country Name City State
Norway Haukeland University Hospital Bergen

Sponsors (2)

Lead Sponsor Collaborator
Haukeland University Hospital Ullevaal University Hospital

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Other Physiology Values of Physiology parameters 25 minutes
Primary Time Time to reaching a threshold of physiology parameters or time limit 25 minutes
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04835545 - Work of Breathing Under Extreme Hypercapnia Induced by Ventilation Insufficiency N/A
Completed NCT02521272 - Hypercapnia and Gas Exchange Under the Avalanche Snow Model (HyperAvaSM) N/A
Active, not recruiting NCT03413878 - Snow Properties and Its Modeling for Studying Gas Exchange Under the Simulated Avalanche Snow N/A
Enrolling by invitation NCT05262894 - Evaluation of Gas Propagation in Snow During Breathing of Subjects Under Simulated Avalanche Snow N/A